FDA Inspection 894744 — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. — FEI 3007886374

The FDA completed an inspection of Mylan Pharmaceuticals Inc. on Sep 4, 2014 in San Carlos, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 4, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Carlos, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.